PSAI

Business news, market intelligence, and global industry analysis.

The Latest

What the latest UTOPIA trial data reveal about UGN-103’s competitive position in LG-IR-NMIBC

Delivery Hero (DHER) stock up 4% to €29.5 as Aspex forces CEO exit and Korea sale opens

What the RIDGE-1 interim results reveal about the future of cardiac gene therapy in ARVC

Hanwha Aerospace targets NATO demand with Romania unmanned systems push at BSDA 2026

Representative image of Dr. Reddy’s pharmaceutical services and API manufacturing operations, highlighting the growing role of PSAI in powering the company’s global expansion strategy.

Can Dr. Reddy’s PSAI business quietly power its next phase of global pharmaceutical growth?

Can Dr. Reddy’s PSAI division unlock global API and CDMO growth? Explore revenues, strategy, investor sentiment, and vertical integration outlook in 2025.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

June 30, 2025